These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32687486)

  • 1. Pyrazolo[4,3-c]pyridine-4-one (PP-4-one) Exhibits Anti-Epileptogenic Effect in Rat Model of Traumatic Epilepsy by Mammalian Target of Rapamycin (mTOR) Signaling Pathway Downregulation.
    Jin J; Shen X; Tian L; He G; Zhang Y
    Med Sci Monit; 2020 Jul; 26():e923919. PubMed ID: 32687486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saikosaponin a functions as anti-epileptic effect in pentylenetetrazol induced rats through inhibiting mTOR signaling pathway.
    Ye M; Bi YF; Ding L; Zhu WW; Gao W
    Biomed Pharmacother; 2016 Jul; 81():281-287. PubMed ID: 27261605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin provides anti-epileptogenic effect in a rat model of post-traumatic epilepsy via deactivation of mTOR signaling pathway.
    Wang F; Chen F; Wang G; Wei S; Fang F; Kang D; Lin Y
    Exp Ther Med; 2018 Jun; 15(6):4763-4770. PubMed ID: 29904395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1β plays a role in the pathogenesis of mesial temporal lobe epilepsy through the PI3K/Akt/mTOR signaling pathway in hippocampal neurons.
    Xiao Z; Peng J; Yang L; Kong H; Yin F
    J Neuroimmunol; 2015 May; 282():110-7. PubMed ID: 25903737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of (immuno)proteasome subunits during epileptogenesis is attenuated by inhibition of the mammalian target of rapamycin pathway.
    Broekaart DWM; van Scheppingen J; Geijtenbeek KW; Zuidberg MRJ; Anink JJ; Baayen JC; Mühlebner A; Aronica E; Gorter JA; van Vliet EA
    Epilepsia; 2017 Aug; 58(8):1462-1472. PubMed ID: 28643873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contusion brain damage in mice for modelling of post-traumatic epilepsy with contralateral hippocampus sclerosis: Comprehensive and longitudinal characterization of spontaneous seizures, neuropathology, and neuropsychiatric comorbidities.
    Golub VM; Reddy DS
    Exp Neurol; 2022 Feb; 348():113946. PubMed ID: 34896334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role of dentate gyrus mechanistic target of rapamycin activation in epileptogenesis in a mouse model of posttraumatic epilepsy.
    Guo D; Han L; Godale CM; Rensing NR; Danzer SC; Wong M
    Epilepsia; 2024 Jul; 65(7):2127-2137. PubMed ID: 38761065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.
    Wong M
    Epilepsia; 2010 Jan; 51(1):27-36. PubMed ID: 19817806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3BDO Alleviates Seizures and Improves Cognitive Function by Regulating Autophagy in Pentylenetetrazol (PTZ)-Kindled Epileptic Mice Model.
    Guo M; Chen S; Lao J; Liang J; Chen H; Tong J; Huang Y; Jia D; Li Q
    Neurochem Res; 2022 Dec; 47(12):3777-3791. PubMed ID: 36243819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote ischemic postconditioning protects the brain from focal ischemia/reperfusion injury by inhibiting autophagy through the mTOR/p70S6K pathway.
    Chen GZ; Shan XY; Li XS; Tao HM
    Neurol Res; 2018 Mar; 40(3):182-188. PubMed ID: 29369005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of mTOR Pathway by Rapamycin Decreases P-glycoprotein Expression and Spontaneous Seizures in Pharmacoresistant Epilepsy.
    Chi X; Huang C; Li R; Wang W; Wu M; Li J; Zhou D
    J Mol Neurosci; 2017 Apr; 61(4):553-562. PubMed ID: 28229367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of post-ischemic seizure by rapamycin is associated with deactivation of mTOR and ERK1/2 pathways in hyperglycemic rats.
    Yang X; Hei C; Liu P; Li PA
    Biochem Biophys Res Commun; 2019 Nov; 520(1):47-53. PubMed ID: 31564412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celecoxib treatment alleviates cerebral injury in a rat model of post-traumatic epilepsy.
    Chen L; Niu Q; Gao C; Du F
    PeerJ; 2023; 11():e16555. PubMed ID: 38077432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective levels of IGF-1 exacerbate epileptogenesis after brain injury.
    Song Y; Pimentel C; Walters K; Boller L; Ghiasvand S; Liu J; Staley KJ; Berdichevsky Y
    Sci Rep; 2016 Aug; 6():32095. PubMed ID: 27561791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy.
    Huang X; Zhang H; Yang J; Wu J; McMahon J; Lin Y; Cao Z; Gruenthal M; Huang Y
    Neurobiol Dis; 2010 Oct; 40(1):193-9. PubMed ID: 20566381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebroventricular administration of ouabain, a Na/K-ATPase inhibitor, activates mTOR signal pathways and protein translation in the rat frontal cortex.
    Kim SH; Yu HS; Park HG; Ha K; Kim YS; Shin SY; Ahn YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():73-82. PubMed ID: 23643758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil contributes to downregulation of the hippocampal interleukin type 2 and 1β mediated PI3K/AKT/mTOR pathway hyperactivation and attenuates neurobehavioral comorbidities in a rat model of temporal lobe epilepsy.
    Mazumder AG; Patial V; Singh D
    Brain Behav Immun; 2019 Jan; 75():84-93. PubMed ID: 30243822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of IL-1β on synaptophysin expression and electrophysiology of hippocampal neurons through the PI3K/Akt/mTOR signaling pathway in a rat model of mesial temporal lobe epilepsy.
    Xiao Z; Peng J; Wu L; Arafat A; Yin F
    Neurol Res; 2017 Jul; 39(7):640-648. PubMed ID: 28372486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-Traumatic Epilepsy and Comorbidities: Advanced Models, Molecular Mechanisms, Biomarkers, and Novel Therapeutic Interventions.
    Golub VM; Reddy DS
    Pharmacol Rev; 2022 Apr; 74(2):387-438. PubMed ID: 35302046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical Kindling as an Experimental Model to Assess the Conventional Drugs in the Treatment of Post-traumatic Epilepsy.
    Aghdash SN; Foroughi G
    CNS Neurol Disord Drug Targets; 2023; 22(10):1417-1428. PubMed ID: 36443981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.